Detection of a biphasic response of hibernating myocardium by dobutamine-stress electrocardiography-gated technetium-99m-tetrofosmin single photon emission computed tomography - A case report

Japanese Circulation Journal

Volumn 63, Issue 9, 1999, Pages 688-691

  Yamagishi, Hiroyuki ^a   Akioka, Kaname ^a   Hirata, Kumiko ^a   Sakanoue, Yuji ^a   Toda, Iku ^a   Yoshiyama, Minoru ^a   Teragaki, Masakazu ^a   Takeuchi, Kazuhide ^a   Yoshikawa, Junichi ^a   Ochi, Hironobu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dobutamine; SPECT; Tetrofosmin

Indexed keywords

DOBUTAMINE; TECHNETIUM 99M;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CELL VIABILITY; COMPUTER PROGRAM; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICULOGRAPHY; HUMAN; IMAGE ANALYSIS; MYOCARDIAL HIBERNATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CORONARY DISEASE; DOBUTAMINE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MYOCARDIAL STUNNING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0347608773     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.688     Document Type: Article

References (18)

1. Wijns W, Vatner SF, Camici PG: Hibernating myocardium. N Engl J Med 1998; 339: 173-181
2. Tillisch J, Brunken R, Marshall R, Schwainger M, Mandelkern M, Phelps M, et al: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888
3. Yamagishi H, Akioka K, Hirata K, Sakanoue Y, Takeuchi K, Yoshikawa J, et al: Dobutamine-stress ECG-gated FDG-PET for detecting viable but dysfunctional myocardium (abstract). Circulation 1998; 98: I-277-I-278
4. 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998; 98: 1869-1874
5. Marcassa C, Marzullo P, Parodi O, Sambuceti G, L'Abbate A: A new method for noninvasive quantitation of segmental myocardial wall thickening using technetium-99m-2-methoxy-isobutyl-isonitrile scintigraphy: results in normal subjects. J Nucl Med 1990; 31: 173-177
6. DePuey EG, Nichols K, Dobrinsky C: Left ventricular ejection fraction assessed from gated technetium-99m sestamibi SPECT. J Nucl Med 1993; 34: 1871-1876
7. Williams KA, Taillon LA: Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images: Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. J Am Coll Cardiol 1996; 27: 173-181
8. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su H, et al: Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147
9. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS: Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997; 30: 1360-1367
10. Germano G, Kavanagh PB, Su H, Mazzanti M, Kiat H, Hachamovitch R. et al: Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images. J Nucl Med 1995; 36: 1107-1114
11. Senior R, Lahiri A: Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the 'biphasic' response of wall thickening during low and high dose dobutamine. J Am Coll Cardiol 1995; 26: 26-32
12. Afridi I, Kleiman NS, Raizner AE, Zobhbi WA: Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91: 663-670
13. Maes A, Flameng W, Nuyts J, Borbers M, Shivalkar B, Ausma J, et al: Histological alterations in chronically hypoperfused myocardium. Circulation 1994; 90: 735-745
14. Kiat H, Maddahi J, Roy LT, Van Train K, Friedman J, Resser K, et al: Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989; 117: 1-11
15. 201Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 1995; 91: 313-319
16. Melon PG, Beanlands RS, DeGrado TR, Nguyen N, Petry NA, Schwaiger M: Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium. J Am Coll Cardiol 1992; 20: 1277-1283
17. Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL: Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993; 34: 1254-1259
18. Cuocolo A, Pace L, Ricciardelli B, Chiarello M, Trimarco B, Salvatore M: Identification of viable myocardium in patients with coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992; 33: 505-511